Patrick Burnett - 03 Jan 2023 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Reporting Person's title: Senior Vice President and Chief Medical Officer
Signature: /s/ Scott Burrows, as Attorney-in-Fact for Patrick Burnett
Issuer symbol: ARQT
Transactions as of: 03 Jan 2023
Transactions value $: -$22,136
Form type: 4
Filing time: 04 Jan 2023, 16:15:26 UTC
Previous filing: 07 Mar 2022
Next filing: 06 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Sale	-$22.1K	-1.48K	-3.43%	$15.01	41.6K	03 Jan 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units ("RSUs"), granted on August 3, 2020. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Content

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units ("RSUs"), granted on August 3, 2020. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Remarks:

Reporting Person's title: Senior Vice President and Chief Medical Officer